SVTR 硅谷科技评论SVTR
← Database
ApplicationsLife Sciences
📍 Atlanta · US South

About

Evidexa is an Atlanta-based healthtech company whose AI interviewer Dexi gathers consented conversations with patients, members and clinicians to build synthetic audiences (SimPath Audiences) that let healthcare teams test protocols, messaging and products before launch.

Capital graph

Founders / team· 2

Jeff GombalaMaitri Patel
⬇
EvidexaJeff GombalaJeff GombalaMaitri PatelMaitri Patel
CompanyInvestorFounders / teamCo-investment (thicker arc = more shared deals, ×N marks the count)Bigger circle = stronger signal (activity / coverage / interest) · ⛶ fullscreen · scroll / pinch to zoom · hover to highlight · drag nodes · click a node to open its profile

Comparable companies· by market

This company

  • Evidexa

    Evidexa is an Atlanta-based healthtech company whose AI interviewer Dexi gathers consented conversations with patients, members and clinicians to build synthetic audiences (SimPath Audiences) that let healthcare teams test protocols, messaging and products before launch.

Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.

Investors that may fit

General Catalyst

40 Life Sciences deals in the last 24 months · 36 in US South

Request intro →

Y Combinator

39 Life Sciences deals in the last 24 months · 32 in US South

Request intro →

Andreessen Horowitz

24 Life Sciences deals in the last 24 months · 22 in US South

Request intro →

Khosla Ventures

21 Life Sciences deals in the last 24 months · 20 in US South

Request intro →

Thrive Capital

18 Life Sciences deals in the last 24 months · 15 in US South

Request intro →

Lightspeed

17 Life Sciences deals in the last 24 months · 15 in US South

Request intro →

Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.

Want to reach Evidexa — for capital, customers, or partnership? Send a short request; SVTR reviews it and brokers the intro, with both sides verified before you meet.

Request an intro to this companySubscribe to Signal